Cyberattacks in MedTech: Lessons from Stryker, Intuitive, & FDA's Cybersecurity Expectations

Cybersecurity threats are no longer theoretical risks for medical device manufacturers. They are operational, regulatory, and patient safety events unfolding in real time.

Recent cybersecurity incidents involving major MedTech companies, including Stryker and Intuitive Surgical, underscore a critical shift in threats. Cyberattacks are no longer confined to IT systems; they have the potential to disrupt manufacturing, impact device functionality, compromise sensitive data, and trigger regulatory compliance scrutiny.

For medical device companies, the implications are clear. Cybersecurity is no longer just a technical discipline. It is a core component of regulatory strategy, quality systems, and business continuity planning.

A New Category of Risk for MedTech

Historically, cybersecurity in MedTech focused on protecting connected devices from unauthorized access or data breaches. Today, the threat landscape is far broader.

Recent incidents have demonstrated that attackers are increasingly targeting:

• Enterprise IT infrastructure

• Manufacturing and operational systems

• Cloud-based platforms supporting device functionality

• Internal communication and documentation systems

In the case of Stryker, reports indicated widespread disruption to internal systems and employee devices. Similarly, incidents affecting Intuitive Surgical have highlighted the vulnerabilities associated with highly interconnected digital ecosystems.

These events reveal an important reality to organizations with mature infrastructure; they are not immune to large-scale cyber disruption.

When Cybersecurity Becomes a Regulatory Issue

Cyber incidents in MedTech do not remain confined to IT or security teams. They quickly become regulatory events. In line with this shift, FDA’s guidance, “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions”, reinforces that cybersecurity must be integrated into both premarket submissions and quality management system processes across the device lifecycle.

Health authorities, including FDA and European regulators, increasingly expect manufacturers to:

• Demonstrate robust cybersecurity risk management across the product lifecycle

• Maintain clear documentation of cybersecurity controls in premarket submissions

• Implement postmarket surveillance processes for cybersecurity threats

• Rapidly assess and report incidents that may impact device safety or performance

A significant cyberattack may trigger:

• Field actions or corrective and preventive actions (CAPAs)

• Regulatory notifications or reporting obligations

• Inspection findings related to quality system deficiencies

• Increased scrutiny during audits or submissions

Under FDA’s evolving cybersecurity expectations and the EU MDR framework, failure to adequately manage cybersecurity risk can be interpreted as a failure to ensure device safety and effectiveness.

Operational Disruption Is a Patient Safety Risk

One of the most important lessons from recent incidents is that cybersecurity events can directly affect patient care.

Disruptions to manufacturing systems can lead to product shortages. Compromised software environments may delay updates or patches. Loss of system access can impact complaint handling, vigilance reporting, or batch release processes.

For companies producing life-sustaining or life-supporting devices, these disruptions carry significant downstream risk.

Cybersecurity resilience is therefore not only about preventing attacks. It is about ensuring continuity of operations in the face of disruption.

Key Gaps Exposed by Recent Incidents

The Stryker and Intuitive Surgical incidents highlight several recurring gaps across the industry:

1. Insufficient Integration Between IT and Quality Systems

Cybersecurity is often managed separately from the quality management system. This disconnect can delay response efforts and complicate regulatory reporting.

2. Limited Incident Response Planning for Regulatory Impact

Many organizations have IT-focused incident response plans but lack clear processes for regulatory communication, documentation, and CAPA initiation.

3. Incomplete Visibility Across Digital Ecosystems

Modern MedTech companies rely on interconnected systems spanning devices, cloud platforms, and enterprise infrastructure. Gaps in visibility can slow detection and containment.

4. Underdeveloped Business Continuity Strategies

Backup systems, redundancy, and recovery planning are not always aligned with regulatory expectations or operational realities.

What Should MedTech Companies Do Now to Avoid Cybersecurity Threats? 

In light of these developments, medical device manufacturers should take a proactive, cross-functional approach to cybersecurity.

Conduct Cybersecurity Gap Assessments

Regular assessments can identify vulnerabilities across systems, processes, and documentation before they become regulatory or operational issues.

Align With Regulatory Expectations

Ensure cybersecurity documentation aligns with FDA’s Cybersecurity in Medical Devices guidance, EU MDR requirements, and applicable international standards such as ISO 13485 and ISO/IEC 27001, with clear traceability between cybersecurity risk management and QMS processes.

Elevate Cybersecurity Within the Quality Management System

Cybersecurity risk management should be fully integrated into QMS processes, including risk management, CAPA, and change control.

Strengthen Incident Response Frameworks

Develop and test incident response plans that include:

• Regulatory reporting pathways

• Cross-functional escalation procedures

• Documentation requirements for audits and inspections

• Build Operational Resilience

Establish redundancy, backup, and recovery capabilities that support both business continuity and regulatory compliance.

Cybersecurity as a Strategic Imperative

The MedTech industry is entering a new phase where cybersecurity incidents are not isolated disruptions. They are enterprise-wide events with regulatory, operational, and reputational consequences.

The lessons from Stryker and Intuitive Surgical are not unique to those organizations. They reflect systemic challenges across the industry.

Companies that treat cybersecurity as a strategic, cross-functional priority that is integrated into regulatory, quality, and operational frameworks will be better positioned to navigate this evolving risk landscape.

From Risk to Readiness: Cybersecurity Support for MedTech

ProPharma partners with medical device and diagnostics companies to strengthen cybersecurity readiness across the product lifecycle.

Our support includes:

• Cybersecurity risk and gap assessments

• Integration of cybersecurity into QMS and CAPA processes

• Regulatory strategy and submission support

• Inspection readiness and remediation

• Postmarket cybersecurity and incident response planning

By aligning cybersecurity with regulatory and quality expectations, we help organizations reduce risk, maintain compliance, and ensure continuity of patient care.